HTG Molecular Diagnostics, Inc. (HTGMQ) Financial Statements
$0.00OTC: HTGMQMarket Cap $221
HTG Molecular Diagnostics, Inc. most recently reported annual revenue of $6.0M, net profit of $-22.0M, revenue has compounded at -16.7% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.